HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Sees Significant Decrease in Short Interest
HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Sees Significant Decrease in Short Interest
HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) was the recipient of a significant decline in short interest in November. As of November 30th, there was short interest totalling 2,400 shares, a decline of 84.1% from the November 15th total of 15,100 shares. Based on an average daily trading volume, of 24,500 shares, the short-interest ratio is presently 0.1 days.
HAVN Life Sciences Price Performance
HAVLF stock remained flat at $0.05 during midday trading on Tuesday. 4,300 shares of the company's stock were exchanged, compared to its average volume of 5,588. HAVN Life Sciences has a 1 year low of $0.05 and a 1 year high of $4.77. The stock's fifty day simple moving average is $0.07 and its 200-day simple moving average is $0.59.
Get HAVN Life Sciences alerts:About HAVN Life Sciences
(Get Rating)
HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.Further Reading
- Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
- What is Market Structure in Trading?
- Institutional Selling Is No Headwind For Nike
- Mullen Automotive Shifts Into Higher Gear
- Why the Cracker Barrel Selloff Looks Overcooked
- It's Still Too Soon to Shop for Kohl's Stock
Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
HAVN Life Sciences Inc. (OTCMKTS:HAVLF – Get Rating) was the recipient of a significant decline in short interest in November. As of November 30th, there was short interest totalling 2,400 shares, a decline of 84.1% from the November 15th total of 15,100 shares. Based on an average daily trading volume, of 24,500 shares, the short-interest ratio is presently 0.1 days.
HAvn Life Science Inc.(場外市場代碼：HAVLF-GET Rating)是11月份空頭股數銷量大幅下降的接收方。截至11月30日，空頭股數共有2400股，比11月15日的15100股下降了84.1%。以日均成交量二萬四千五百股計算，目前短息比率為零點一天。
HAVN Life Sciences Price Performance
擁有生命科學的性價比
HAVLF stock remained flat at $0.05 during midday trading on Tuesday. 4,300 shares of the company's stock were exchanged, compared to its average volume of 5,588. HAVN Life Sciences has a 1 year low of $0.05 and a 1 year high of $4.77. The stock's fifty day simple moving average is $0.07 and its 200-day simple moving average is $0.59.
週二午盤交易中，HAVLF股價持平於0.05美元。該公司股票成交量為4300股，而其平均成交量為5588股。HAvn Life Sciences的一年低點為0.05美元，一年高位為4.77美元。該股的50日簡單移動均線為0.07美元，200日簡單移動均線為0.59美元。
About HAVN Life Sciences
關於HAVN生命科學
(Get Rating)
(獲取評級)
Further Reading
進一步閱讀
- Get a free copy of the StockNews.com research report on HAVN Life Sciences (HAVLF)
- What is Market Structure in Trading?
- Institutional Selling Is No Headwind For Nike
- Mullen Automotive Shifts Into Higher Gear
- Why the Cracker Barrel Selloff Looks Overcooked
- It's Still Too Soon to Shop for Kohl's Stock
- 免費獲取StockNews.com關於HAVN生命科學的研究報告(HAVLF)
- 交易中的市場結構是什麼？
- 機構銷售對耐克來說不是逆風
- 馬倫汽車轉向更高檔位
- 為什麼餅乾桶拋售看起來有點過頭了
- 現在購買科爾的股票還為時過早
Receive News & Ratings for HAVN Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HAVN Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
接受《HAVN生命科學日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對HAVN生命科學和相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。
風險及免責聲明
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧